SPRINGFIELD, IL – “Last week, Gov. JB Pritzker signed legislation that will improve access to care for cancer patients by expanding coverage for biomarker testing. HB1779 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments. Dubbed ‘the right treatment, to the right patient, at the right time,’ precision medicine plays a critical role in improving cancer outcomes. With this first in the nation law, more Illinoisans will be able to benefit from the latest advances in cancer treatment.
“ACS CAN thanks Leader Flowers and Leader Munoz for their leadership on biomarker testing legislation and Gov. Pritzker signing this important piece of legislation.”
###
About ACS CAN at 20
The American Cancer Society Cancer Action Network (ACS CAN) makes cancer a top priority for policymakers at every level of government. ACS CAN empowers volunteers across the country to make their voices heard to influence evidence-based public policy change that saves lives. We believe everyone should have a fair and just opportunity to prevent, find, treat, and survive cancer. Since 2001, as the American Cancer Society’s nonprofit, nonpartisan advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and made workplaces, including restaurants and bars, smoke-free. As we mark our 20th anniversary, we’re more determined than ever to stand together with our volunteers and save more lives from cancer. Join the fight by visiting www.fightcancer.org.
